Armo Biosciences, Inc.
SEC CIK 1693664 · ARMO · last insider filing 2018-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Orbimed Advisors LLC | Director | filed 2018 - 2018 |
| Seidenberg Beth C | Director | filed 2018 - 2018 |
| VAN Vlasselaer Peter | Director · President and CEO | filed 2018 - 2018 |
| Gordon Carl L | Director | filed 2018 - 2018 |
| Legault Pierre | Director | filed 2018 - 2018 |
| Cui Xiangmin | Director | filed 2018 - 2018 |
| Orbimed Capital GP IV LLC | Director | filed 2018 - 2018 |
| Orbimed Capital GP V LLC | Director | filed 2018 - 2018 |
| Rizvi Naiyer | Director | filed 2018 - 2018 |
| Xu Stella | Director | filed 2018 - 2018 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Cross Herb | Chief Financial Officer | filed 2018 - 2018 |
| Leveque Joseph | Chief Medical Officer | filed 2018 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.